SciClone Pharmaceuticals (SCLN)

Add to Watchlists Create an Alert
4.97 +0.20  +4.19%   NASDAQ May 23, 4:59PM BATS Real time Currency in USD

SciClone Pharmaceuticals Cash from Investing Quarterly:

-0.167M for Dec. 31, 2012
View Full Chart

SciClone Pharmaceuticals Cash from Investing Quarterly Chart

    SciClone Pharmaceuticals Historical Cash from Investing Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    Dec. 31, 2012 -0.167M
    Sept. 30, 2012 -0.172M
    June 30, 2012 -0.11M
    March 31, 2012 -0.754M
    Dec. 31, 2011 0.83M
    Sept. 30, 2011 0.32M
    June 30, 2011 -22.34M
    March 31, 2011 2.348M
    Dec. 31, 2010 4.135M
    Sept. 30, 2010 0.501M
    June 30, 2010 -6.555M
    March 31, 2010 0.603M
    Dec. 31, 2009 -0.022M
    Sept. 30, 2009 -0.013M
    June 30, 2009 -0.064M
    March 31, 2009 -0.049M
    Dec. 31, 2008 -0.27M
    Sept. 30, 2008 -0.523M
    June 30, 2008 0.355M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
       
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro
    Sept. 30, 2000 Go Pro

    About Cash From Investing

    An item on a company's cash flow statement. Lists aggregate change in cash position resulting from investing activities. Includes the company's cash inflows and outflows from investments in financial markets and the sale of capital assets.
    Learn More

    Get data for

    SCLN Cash from Investing Quarterly Benchmarks

    Companies
    Lannett Company -5.038M
    DepoMed 6.621M
    POZEN 18.64M

    SCLN Cash from Investing Quarterly Rankings

    Overall 80th percentile
    1529 of 8006
    Sector 62nd percentile
    259 of 686 in Healthcare
    Industry 66th percentile
    23 of 68 in Drug Manufacturers - Specialty & Generic

    SCLN Cash from Investing Quarterly Range, Past 5 Years

    Minimum -22.34M Jun 2011
    Maximum 4.135M Dec 2010
    Average -1.155M